Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 269

1.

Human cytochrome p450 inhibition and metabolic-intermediate complex formation by goldenseal extract and its methylenedioxyphenyl components.

Chatterjee P, Franklin MR.

Drug Metab Dispos. 2003 Nov;31(11):1391-7.

PMID:
14570772
[PubMed - indexed for MEDLINE]
Free Article
2.

An in vitro evaluation of cytochrome P450 inhibition and P-glycoprotein interaction with goldenseal, Ginkgo biloba, grape seed, milk thistle, and ginseng extracts and their constituents.

Etheridge AS, Black SR, Patel PR, So J, Mathews JM.

Planta Med. 2007 Jul;73(8):731-41. Epub 2007 Jul 5.

PMID:
17611934
[PubMed - indexed for MEDLINE]
3.

Drug interactions with calcium channel blockers: possible involvement of metabolite-intermediate complexation with CYP3A.

Ma B, Prueksaritanont T, Lin JH.

Drug Metab Dispos. 2000 Feb;28(2):125-30.

PMID:
10640508
[PubMed - indexed for MEDLINE]
Free Article
4.

Interaction of irinotecan (CPT-11) and its active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38) with human cytochrome P450 enzymes.

Hanioka N, Ozawa S, Jinno H, Tanaka-Kagawa T, Nishimura T, Ando M, Sawada Ji J.

Drug Metab Dispos. 2002 Apr;30(4):391-6.

PMID:
11901092
[PubMed - indexed for MEDLINE]
Free Article
5.

Characterization of the selectivity and mechanism of human cytochrome P450 inhibition by the human immunodeficiency virus-protease inhibitor nelfinavir mesylate.

Lillibridge JH, Liang BH, Kerr BM, Webber S, Quart B, Shetty BV, Lee CA.

Drug Metab Dispos. 1998 Jul;26(7):609-16.

PMID:
9660842
[PubMed - indexed for MEDLINE]
Free Article
7.

In vitro inhibitory effects of troglitazone and its metabolites on drug oxidation activities of human cytochrome P450 enzymes: comparison with pioglitazone and rosiglitazone.

Yamazaki H, Suzuki M, Tane K, Shimada N, Nakajima M, Yokoi T.

Xenobiotica. 2000 Jan;30(1):61-70.

PMID:
10659951
[PubMed - indexed for MEDLINE]
8.

Metabolite-P450 complex formation by methylenedioxyphenyl HIV protease inhibitors in rat and human liver microsomes.

Chiba M, Nishime JA, Chen IW, Vastag KJ, Sahly YS, Kim BM, Dorsey BD, Vacca JP, Lin JH.

Biochem Pharmacol. 1998 Jul 15;56(2):223-30.

PMID:
9698076
[PubMed - indexed for MEDLINE]
9.

Characterization of the selectivity and mechanism of cytochrome P450 inhibition by dimethyl-4,4'-dimethoxy-5,6,5',6'-dimethylenedioxybiphenyl-2,2'-dicarboxylate.

Kim JY, Baek M, Lee S, Kim SO, Dong MS, Kim BR, Kim DH.

Drug Metab Dispos. 2001 Dec;29(12):1555-60.

PMID:
11717174
[PubMed - indexed for MEDLINE]
Free Article
10.

Mechanism-based inhibition of human liver microsomal cytochrome P450 1A2 by zileuton, a 5-lipoxygenase inhibitor.

Lu P, Schrag ML, Slaughter DE, Raab CE, Shou M, Rodrigues AD.

Drug Metab Dispos. 2003 Nov;31(11):1352-60.

PMID:
14570767
[PubMed - indexed for MEDLINE]
Free Article
11.

Identification and characterization of potent CYP3A4 inhibitors in Schisandra fruit extract.

Iwata H, Tezuka Y, Kadota S, Hiratsuka A, Watabe T.

Drug Metab Dispos. 2004 Dec;32(12):1351-8. Epub 2004 Sep 1.

PMID:
15342469
[PubMed - indexed for MEDLINE]
Free Article
12.

The inhibitory effect of tannic acid on cytochrome P450 enzymes and NADPH-CYP reductase in rat and human liver microsomes.

Yao HT, Chang YW, Lan SJ, Yeh TK.

Food Chem Toxicol. 2008 Feb;46(2):645-53. Epub 2007 Sep 15.

PMID:
17950511
[PubMed - indexed for MEDLINE]
13.

Inhibitory effects of azelastine and its metabolites on drug oxidation catalyzed by human cytochrome P-450 enzymes.

Nakajima M, Ohyama K, Nakamura S, Shimada N, Yamazaki H, Yokoi T.

Drug Metab Dispos. 1999 Jul;27(7):792-7.

PMID:
10383922
[PubMed - indexed for MEDLINE]
Free Article
14.

Inhibitory effect of glyburide on human cytochrome p450 isoforms in human liver microsomes.

Kim KA, Park JY.

Drug Metab Dispos. 2003 Sep;31(9):1090-2.

PMID:
12920163
[PubMed - indexed for MEDLINE]
Free Article
15.

Inhibition of human drug metabolizing cytochrome P450 by buprenorphine.

Umehara K, Shimokawa Y, Miyamoto G.

Biol Pharm Bull. 2002 May;25(5):682-5.

PMID:
12033517
[PubMed - indexed for MEDLINE]
Free Article
16.

Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: prediction of in vivo drug-drug interactions.

Katoh M, Nakajima M, Shimada N, Yamazaki H, Yokoi T.

Eur J Clin Pharmacol. 2000 Feb-Mar;55(11-12):843-52.

PMID:
10805063
[PubMed - indexed for MEDLINE]
17.

Inhibition of cytochrome P450 3A4 by a pyrimidineimidazole: Evidence for complex heme interactions.

Hutzler JM, Melton RJ, Rumsey JM, Schnute ME, Locuson CW, Wienkers LC.

Chem Res Toxicol. 2006 Dec;19(12):1650-9.

PMID:
17173379
[PubMed - indexed for MEDLINE]
18.

Metabolite-cytochrome P450 complex formation by methylenedioxyphenyl lignans of Piper cubeba: mechanism-based inhibition.

Usia T, Watabe T, Kadota S, Tezuka Y.

Life Sci. 2005 Apr 1;76(20):2381-91.

PMID:
15748631
[PubMed - indexed for MEDLINE]
19.

Effects of herbal products and their constituents on human cytochrome P450(2E1) activity.

Raner GM, Cornelious S, Moulick K, Wang Y, Mortenson A, Cech NB.

Food Chem Toxicol. 2007 Dec;45(12):2359-65. Epub 2007 Jun 15.

PMID:
17658211
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

In vitro inhibitory effect of 1-aminobenzotriazole on drug oxidations in human liver microsomes: a comparison with SKF-525A.

Emoto C, Murase S, Sawada Y, Iwasaki K.

Drug Metab Pharmacokinet. 2005 Oct;20(5):351-7.

PMID:
16272753
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk